文献速递肝病

无创检查不能准确区分非酒精性脂肪性肝炎与单纯性脂肪变:一项系统评价与荟萃分析

Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-08-22

该系统评价与荟萃分析检索1990至2016年PubMed、Medline和Embase数据库,纳入122项以肝活检为参考标准的研究,评估无创血液标志物区分非酒精性脂肪性肝炎(NASH)与单纯性脂肪变(SS)的准确性。合并分析显示,常用标志物及评分系统的合并灵敏度和特异度均未达到80%,目前尚无标志物或评分系统可推荐用于临床实践区分NASH与SS。

要点

  • 122项研究中219种血液标志物及22种其他诊断试验被评估,但无一合并灵敏度和特异度均≥80%。
  • 丙氨酸氨基转移酶合并灵敏度63.5%、特异度74.4%,脂联素72.0%和75.7%,CK18-M30为68.4%和74.2%。
  • NASH test区分NASH与边缘性NASH加单纯性脂肪变的灵敏度22.9%、特异度95.3%。

核心结论

  • 荟萃分析未发现任何试验区分NASH与SS的合并灵敏度和特异度达到高水平(≥80%)。
  • 某些血液标志物在单项研究的评分系统中可达到≥80%灵敏度和特异度识别NASH患者。
  • 目前尚无标志物或评分系统可推荐用于临床实践区分NASH与单纯性脂肪变。

研究设计与样本

  • 系统检索PubMed、Medline和Embase数据库(1990-2016年),限定英文全文和人类成人,共识别2608篇文章。
  • 两名独立评价者筛选出122篇以肝活检为参考标准的合格文章。
  • 若至少有2项研究可用,则使用R软件Meta-Analysis Package(metafor)确定合并灵敏度和特异度。

主要发现

  • 122项研究中识别出219种不同血液标志物(107种单一标志物和112种评分系统)及22种其他诊断试验用于区分NASH与单纯性脂肪变。
  • 常规生化检查中丙氨酸氨基转移酶合并灵敏度63.5%、合并特异度74.4%。
  • 炎症标志物中脂联素合并灵敏度72.0%、合并特异度75.7%。
  • 细胞死亡或增殖标志物中CK18-M30合并灵敏度68.4%、合并特异度74.2%。
  • 代谢标志物中胰岛素抵抗稳态模型评估合并灵敏度69.0%、合并特异度72.7%。

关键数值与推荐

  • NASH test区分NASH与边缘性NASH加单纯性脂肪变的合并灵敏度22.9%、合并特异度95.3%。
  • GlycoNASH test合并灵敏度67.1%、合并特异度63.8%。
  • 未发现合并灵敏度和特异度均≥80%的试验。

临床怎么用

  • 目前尚无标志物或评分系统可推荐用于临床实践区分NASH与单纯性脂肪变。
  • 某些血液标志物在单项研究的评分系统中可达到≥80%灵敏度和特异度识别NASH患者。
  • 亟需重复研究和更标准化的研究设计。

局限性

  • 亟需重复研究和更标准化的研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Nonalcoholic fatty liver disease is a rapidly increasing health problem. Liver biopsy analysis is the most sensitive test to differentiate between nonalcoholic steatohepatitis (NASH) and simple steatosis (SS), but noninvasive methods are needed. We performed a systematic review and meta-analysis of noninvasive tests for differentiating NASH from SS, focusing on blood markers. METHODS: We performed a systematic search of the PubMed, Medline and Embase (1990-2016) databases using defined keywords, limited to full-text papers in English and human adults, and identified 2608 articles. Two independent reviewers screened the articles and identified 122 eligible articles that used liver biopsy as reference standard. If at least 2 studies were available, pooled sensitivity (sensp) and specificity (specp) values were determined using the Meta-Analysis Package for R (metafor). RESULTS: In the 122 studies analyzed, 219 different blood markers (107 single markers and 112 scoring systems) were identified to differentiate NASH from simple steatosis, and 22 other diagnostic tests were studied. Markers identified related to several pathophysiological mechanisms. The markers analyzed in the largest proportions of studies were alanine aminotransferase (sensp, 63.5% and specp, 74.4%) within routine biochemical tests, adiponectin (sensp, 72.0% and specp, 75.7%) within inflammatory markers, CK18-M30 (sensp, 68.4% and specp, 74.2%) within markers of cell death or proliferation and homeostatic model assessment of insulin resistance (sensp, 69.0% and specp, 72.7%) within the metabolic markers. Two scoring systems could also be pooled: the NASH test (differentiated NASH from borderline NASH plus simple steatosis with 22.9% sensp and 95.3% specp) and the GlycoNASH test (67.1% sensp and 63.8% specp). CONCLUSION: In the meta-analysis, we found no test to differentiate NASH from SS with a high level of pooled sensitivity and specificity (≥80%). However, some blood markers, when included in scoring systems in single studies, identified patients with NASH with ≥80% sensitivity and specificity. Replication studies and more standardized study designs are urgently needed. At present, no marker or scoring system can be recommended for use in clinical practice to differentiate NASH from simple steatosis.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Verhaegh P, Bavalia R, Winkens B, et al. Noninvasive Tests Do Not Accurately Differentiate Nonalcoholic Steatohepatitis From Simple Steatosis: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2017. PMID: 28838784. doi:10.1016/j.cgh.2017.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。